| Achondroplasia Mutation Analysis (FGFR3) |
MG3001 |
5ml Blood in K2 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| ACTN3 Sports Gene Genotyping |
MG3002 |
5 ml Blood in K2 EDTA Tube (LCT)/ Buccal Swab |
Tue |
15 days |
Molecular Genetics |
| ADRB2 Gentoyping for Beta-2 Agonist Responsiveness |
MG3101 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Fri |
8 days |
Molecular Genetics |
| AKT1 Mutation Analysis (E17K) |
MG3004 |
5 ml Blood or 3 ml Bone marrow in K2 EDTA Tube (LCT) |
Tue |
7 days |
Molecular Genetics |
| Alpha 1 Antitrypsin Genotype Analysis (Z, X , M Mutations) |
MG3003 |
5ml Blood in K2 EDTA Tube (LCT) |
Fri |
15 days |
Molecular Genetics |
| Alpha Thalassemia PCR |
MG3005 |
5ml Blood in K2 EDTA Tube (LCT) |
Sat |
15 days |
Molecular Genetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) amniotic fluid |
MG3102 |
5 ml Amniotic Fluid in Sterile Container |
Mon, Thu |
5 days |
Molecular Genetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) blood |
MG3103 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Thu |
5 days |
Molecular Genetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) POC |
MG3104 |
Product of Conception (POC) in a sterile container with Normal Saline & Gentamycine. |
Mon, Thu |
5 days |
Molecular Genetics |
| Aneuploidy PCR Detection (13,15,16,18,21,22,X&Y) SEMEN |
MG3105 |
2 ml Semen in Sterile Container |
Mon, Thu |
5 days |
Molecular Genetics |
| Angelman Syndrome Methylation PCR |
MG3106 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Fri |
15 days |
Molecular Genetics |
| Angiotensin Converting Enzyme (ACE) I/D Polymorphism (Insertion/Deletion) |
MG3006 |
5 ml Blood in K2/K3 EDTA Tube (LCT)/ Buccal Swab |
Mon |
7 days |
Molecular Genetics |
| Apolipoprotein B (APOB) Mutation Analysis |
MG3007 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Mon |
7 days |
Molecular Genetics |
| ATN1 Trinucleotide Repeat Analysis (DRPLA-Dentatorubral-pallidoluysian atrophy) |
MG3008 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| Beta Thalassemia Molecular Analysis (Beta globin (HBB) gene sequencing) |
MG3009 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Beta-thalassemia 5 Mutation Analysis |
MG3010 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| BRAF Target Exon Analysis (Exon 11 & 15) |
MG3011 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow |
Daily |
7 days |
Molecular Genetics |
| BRAF V600E Mutation Analysis |
MG3012 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow |
Daily |
7 days |
Molecular Genetics |
| Calreticulin (CALR) Mutation Analysis |
MG3013 |
4 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
8 days |
Molecular Genetics |
| CEBPA Mutation Analysis |
MG3014 |
5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) |
Mon |
10 days |
Molecular Genetics |
| cKIT Mutation Analysis (D816V) |
MG3015 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue |
8 days |
Molecular Genetics |
| CSF3R Mutation Analysis |
MG3129 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| CTNNB1 Mutation Analysis |
MG3128 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| CYP 2C19 Genotype Analysis (Clopidogrel Sensitivity Test) |
MG3019 |
5 ml Blood in K2/K3 EDTA Tube (LCT)/ Buccal Swab |
Daily |
7 days |
Molecular Genetics |
| CYP3A4*22 Genotype Analysis for Statins (Lipid Lowering Drugs) |
MG3016 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Fri |
12 days |
Molecular Genetics |
| Cystic Fibrosis - CFTR Single Mutation Test (DeltaF508) |
MG3018 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Cystic Fibrosis 5 Common Mutation Test (CFTR-DeltaF508, R117H, 5T, G542X, G551D) |
MG3017 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| DMD Mutation Screening 24 Exons (For Symptomatic Male Samples) |
MG3020 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Tue, Fri |
15 days |
Molecular Genetics |
| DPD Gene Mutation for 5-Fluorouracil Toxicity Test (DPYD IVS14+1G>A) |
MG3021 |
5 ml Blood K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| EGFR Target Exons Sequencing (Exon 18, 19, 20, & 21) |
MG3022 |
Tumor Tissue or FFPE Block or FNA |
Daily |
5 days |
Molecular Genetics |
| Estrogen Receptor 1 (ESR1) Mutation Analysis (Exon 7 & 8) |
MG3107 |
Tumor Tissue or FFPE Block or FNA |
Fri |
7 days |
Molecular Genetics |
| Factor V Leiden Mutation Analysis (FVL-R506Q) |
MG3024 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| FIP1L1-PDGFR-A Gene Rearrangement PCR |
MG3096 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Sat |
15 days |
Molecular Genetics |
| FLT3 Mutation Analysis (ITD & D835Y) |
MG3023 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Wed,Sat |
5 days |
Molecular Genetics |
| Fragile X Repeat Expansion Analysis |
MG3026 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Tue, Fri |
3 weeks |
Molecular Genetics |
| Friedreich's Ataxia Repeat Expansion Analysis |
MG3025 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
daily |
15 days |
Molecular Genetics |
| FSHR Mutation Analysis (S680 allele) |
MG3027 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| G6PD deficiency Three Mutation Panel (G6PD Mediterranean (C563T), Kerala-Kalyan (G949A) & Orissa (C131G) |
MG3031 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Glycoprotein IIIa Mutation Analysis |
MG3030 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| GNAS Mutation Analysis (Codon 201 & 227) Exon 8 & 9 |
MG3029 |
FFPE OR Fresh tumor tissue |
Daily |
7 days |
Molecular Genetics |
| HADHA Mutation Analysis |
MG3033 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Haptoglobin Genotype Analysis |
MG3032 |
6 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HBB Beta Globin Full Gene Sequence Analysis |
MG3034 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Hemoglobin D Mutation (Iran / Punjab) |
MG3035 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Wed |
10 days |
Molecular Genetics |
| Hemoglobin E Mutation Analysis Blood |
MG3036 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Wed |
10 days |
Molecular Genetics |
| Hereditary Hemochromatosis (HFE) Three Mutation Analysis |
MG3037 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HLA Genotyping For Narcolepsy |
MG3038 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HLA-B1502 Genotyping Test (Carbamazepine Hypersensitivity) |
MG3039 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
4 days |
Molecular Genetics |
| HLA-B27 Genotyping Analysis (Ankylosing Spondylitis) |
MG3043 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Mon, Fri |
7 days |
Molecular Genetics |
| HLA-B5701 Genotype Test (Abacavir Hypersensitivity) |
MG3042 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Wed,Sat |
10 days |
Molecular Genetics |
| HLA-B5801 Genotyping Test (Allopurinol Hypersensitivity) |
MG3040 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HmLH-1 & HMSH-2 (Repair Genes) Molecular Analysis |
MG3028 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HRAS Mutation Analysis |
MG3044 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Huntington Disease Mutation Analysis |
MG3045 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Mon |
15 days |
Molecular Genetics |
| IDH1 & IDH2 Target Mutation Analysis |
MG3047 |
FFPE Block or Tumor Tissue/ 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Imatinib Resistance Mutation Analysis (IRMA) |
MG3048 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Fri |
7 days |
Molecular Genetics |
| Inosine Triphosphatase & Interleukin 28B (ITPA) Genotype Analysis |
MG3046 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Inv 16 - t(16-16) (p13q22) Gene Rearrangement Qualitative PCR |
MG3095 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
7 days |
Molecular Genetics |
| JAK2 Target Exons Sequence Analysis |
MG3050 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| JAK2 V617F Mutation Analysis |
MG3100 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| KIT Exon 17 Mutation Analysis |
MG3126 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| KRAS One Mutation Analysis |
MG3053 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| KRAS Target Exons Screening |
MG3051 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Tue,Fri |
10 days |
Molecular Genetics |
| KRAS Two Mutation Analysis |
MG3052 |
Daily |
7 days |
7 days |
Molecular Genetics |
| LHB Mutation Test [Trp8Arg & Ile15Thr] |
MG3114 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| MITO - Leigh syndrome Target Mutation Analysis |
MG3115 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
3 weeks |
Molecular Genetics |
| MITO - LHON Target Mutation Analysis (Leb Hered Optic atrophy ) |
MG3116 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
3 weeks |
Molecular Genetics |
| MITO - MELAS Target Mutation Analysis |
MG3117 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| MITO - MERRF Target Mutation Analysis (MT-TK - m.8344A>G) |
MG3118 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| MITO-NARP Target Mutation Analysis (Neuropathy, ataxia, and retinitis pigmentosa) |
MG3119 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| MPL1 Mutation Analysis (Myeloproliferative Leukemia) |
MG3054 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| MTHFR Two Mutation Test (C677T & A1298C) |
MG3055 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Myotonic dystrophy (DM) Molecular Analysis |
MG3056 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| Nonsyndromic Hearing loss Mutation Analysis (Connexin-26) |
MG3120 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| NPM1 Mutation Analysis |
MG3057 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Wed, Sat |
5 days |
Molecular Genetics |
| NRAS Target Exon Sequence Analysis |
MG3058 |
Tumor Tissue or FFPE Block |
Mon |
7 days |
Molecular Genetics |
| NUDT15 Genotyping Analysis (Thiopurine induced Toxicity) |
MG3121 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| PAI-1 Mutation Analysis (4G/5G allele) |
MG3059 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| PDGFRA Target Exon Sequence Analysis |
MG3127 |
5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) or FFPE or Tumor Tissue or FNA |
Daily |
7 days |
Molecular Genetics |
| PDGFRA Target Exons Sequence Analysis |
MG3060 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
10 days |
Molecular Genetics |
| Phenytoin Genetic Test |
MG3041 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| PIK3CA Target Mutation Analysis |
MG3061 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| Platinum Drug Response Genetic Test (GSTP1, XRCC1, ERCC2) |
MG3062 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Praderwilli Syndrome Methylation PCR |
MG3122 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Fri |
15 days |
Molecular Genetics |
| Prothrombin Mutation Analysis (G20210A) |
MG3063 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| RET High Risk Mutation (Exon 10 &11) |
MG3064 |
FFPE or Tumor Tissue or FNA; 5ml Blood for Family Screening |
Daily |
7 days |
Molecular Genetics |
| RETT Syndrome Molecular Anaysis (MECP2 Gene Sequencing) |
MG3123 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Sat |
12 days |
Molecular Genetics |
| SBMA (Spinobulbar Muscular Atrophy) Molecular Analysis |
MG3065 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-1 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3066 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-10 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3072 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-12 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3073 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-17 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3074 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-2 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3067 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-3 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3068 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-6 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3069 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-7 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3070 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-8 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3071 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| Sickle Cell Anemia Mutation Analysis |
MG3075 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| SLCO1B1 Genotype Analysis [Statin Induced Myopathy Risk Analysis] |
MG3078 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Spinal Muscular Atrophy (SMA1) Exon 7 Del/Dup Analysis |
MG3076 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
2 weeks |
Molecular Genetics |
